A. Isaksson et B. Hultberg, SERUM BETA-HEXOSAMINIDASE ISOENZYMES ARE PRECURSOR FORMS, Scandinavian journal of clinical & laboratory investigation, 55(5), 1995, pp. 433-440
The lysosomal enzyme beta-hexosaminidase (Hex, EC 3.2.1.52) was purifi
ed from human serum and placental tissue. On gel chromatography, Hex i
soenzymes (Hex A, B and P) from serum showed a molecular weight of abo
ut 150 kDa, i.e. higher than the 120 kDa found for the placental (tiss
ue) isoenzymes (Hex A and B). Sodium dodecyl sulphate polyacrylamide g
el electrophoresis of non-reduced serum Hex A revealed two different s
ubunits, denoted alpha and beta, corresponding to apparent molecular w
eights of 70 and 67 kDa, respectively. Serum Hex B and Hex P were comp
osed of beta-subunits only. In contrast, the apparent molecular weight
s of the alpha- and beta-subunits originating from tissue were both 55
kDa. Reduction of tissue Hex A and Hex B resulted in cleavage of the
beta-subunit into several fragments, whereas the beta-subunit in serum
forms was resistant to this treatment. These results are consistent w
ith the serum forms never having entered the lysosome prior to their r
elease to the extracellular environment and serum forms can therefore
be classified as precursor molecules. No mature (tissue) forms were fo
und in serum. Isoelectric focusing before and after neuraminidase trea
tment of the serum isoenzymes showed that they all contained sialic ac
id and that Hex B and Hex P had an identical focusing pattern after de
sialylation. Serum beta-hexosaminidase is frequently elevated in liver
disease, alcoholism and pregnancy and the results of the present stud
y indicate that this is due to an increased synthesis and secretion of
hypersialylated beta-subunits, rather than to release of intralysosom
ally stored enzyme.